ArticleThe Biochemical journal2026
Identification and functional characterization of two CXCL17 paralogs from zebrafish.
Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
C-X-C motif chemokine ligand 17 (CXCL17) and its receptor G protein-coupled receptor 25 (GPR25) have been identified as a significant pair in regulating immunity, but CXCL17 orthologs have not yet been identified from non-mammalian vertebrates. This study aimed to identify and characterize non-mammalian CXCL17 orthologs based on key features of mammalian CXCL17s, such as a C-terminal Xaa-Pro-Yaa motif, a signal peptide, and six cysteine residues. Two possible CXCL17 paralogs were identified from zebrafish (Danio rerio): Dr-CXCL17 (encoded by zgc:158701) and Dr-CXCL17-like (encoded by si:dkey-112a7.5). Both are previously uncharacterized proteins with unknown functions because they lack overall sequence similarity to known mammalian CXCL17s. For functional characterization, recombinant Dr-CXCL17 and Dr-CXCL17-like were prepared via overexpression in Escherichia coli and subsequent in vitro refolding, and their activity was tested using NanoLuc Binary Technology (NanoBiT)-based β-arrestin recruitment assays, NanoBiT-based ligand‒ receptor binding assays, and chemotaxis assays. The results showed that both Dr-CXCL17 and Dr-CXCL17-like tightly bound to and efficiently activated zebrafish GPR25 (Dr-GPR25) and induced chemotactic movement in transfected human embryonic kidney (HEK) 293T cells expressing the receptor. Deletion of three C-terminal residues in both paralogs almost eliminated their binding, activation, and chemotactic effects, which suggests that this fragment is crucial for their function. Homologs of Dr-CXCL17 or Dr-CXCL17-like were retrieved from several other ray-finned fish species, indicating that two CXCL17 paralogs are present in certain fish species and function as endogenous agonists for the fish GPR25 receptor. The identification of fish CXCL17 orthologs suggests that the CXCL17‒GPR25 pair likely originated in ancient fishes and was conserved across vertebrate lineages. This work represents the first identification of CXCL17 orthologs in non-mammalian vertebrates, paving the way for future functional studies of this ligand‒receptor pair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.